Search

Displaying results 8781 - 8790 of 10000 in total
  1. Drug

    Icanbelimod

    go.drugbank.com/drugs/DB21572
    Experimental

    Icanbelimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Icanbelimod is a immunomodulator, both stimulant/suppressive and stimulant.

  2. Drug

    Uplarafenib

    go.drugbank.com/drugs/DB21661
    Experimental

    Uplarafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Uplarafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.

  3. Drug

    Fosrolapitant

    go.drugbank.com/drugs/DB21723
    Investigational

    Fosrolapitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Fosrolapitant is a neurokinin NK1​ (substance P) receptor antagonist.

  4. Drug

    Flezurafenib

    go.drugbank.com/drugs/DB21725
    Experimental

    Flezurafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Flezurafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.

  5. Drug

    Vormatrigine

    go.drugbank.com/drugs/DB21731
    Investigational

    Vormatrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Vormatrigine is a sodium channel blocker, signal transduction modulator.

  6. Drug

    Quisovalimab

    go.drugbank.com/drugs/DB16482
    Investigational

  7. Drug

    Zinlirvimab

    go.drugbank.com/drugs/DB18867
    Investigational

    Zinlirvimab is under investigation in clinical trial NCT03707977 (Dual Bnab Treatment in Children).

    Synonyms: Anti-hiv-1 human monoclonal antibody targeting v3 glycan supersite on the hiv-1 envelope protein (10-1074)
  8. Drug

    PF-06835919

    go.drugbank.com/drugs/DB19163
    Investigational

    PF-06835919 is under investigation in clinical trial NCT05463575 (Ketohexokinase Inhibition in NAFLD).

  9. Drug

    Norethandrolone

    go.drugbank.com/drugs/DB12787
    Investigational

    Norethandrolone is under investigation in clinical trial NCT00700544 (Treatment Outcome in Elderly Patients).

  10. Drug

    Jaktinib

    go.drugbank.com/drugs/DB17545
    Investigational

    Jaktinib is under investigation in clinical trial NCT04866056 (Jaktinib and Azacitidine in Treating Patients With MDS With MF or MDS/MPN With MF.). … Jaktinib is a JAK 1, JAK 2 and JAK 3 inhibitor, being developed by Suzhou Zelgen Biopharmaceuticals.